髄膜炎菌ワクチン市場：タイプ別、販売チャネル別、年齢層別、地域別

髄膜炎菌ワクチンの世界市場は、2025年には45億3,000万米ドルと推定され、2032年には90億5,000万米ドルに達すると予測され、2025～2032年にかけてCAGR10.4%で成長する見込みです。

図.髄膜炎菌ワクチン市場シェア（%）、2025年地域別

髄膜炎菌感染症とは、髄膜炎や敗血症を引き起こす細菌感染症のことで、速やかに治療しなければ、重篤な病気や死に至ることさえあります。侵襲性髄膜炎菌性疾患の有病率の上昇に加え、このような感染症に対する効果的なワクチンが利用可能であるという認識が高まることで、髄膜炎菌ワクチンの需要が世界的に高まる可能性があります。さらに、新たな血清型に対する新しい結合型ワクチンの研究開発が進行中であり、世界中でワクチン接種プログラムが拡大していることから、近い将来、市場関係者に多くの機会を提供することができます。しかし、ワクチン開発に関連する高コストや代替品の脅威といった要因が市場成長の妨げとなる可能性があります。

市場力学

世界の髄膜炎菌ワクチン市場成長の原動力は、人口動態や生活様式の変化による侵襲性髄膜炎菌疾患の世界の有病率の上昇です。世界保健機関（WHO）によると、世界中で毎年約120万件の髄膜炎菌性髄膜炎が発生し、約13万5,000人が死亡しています。国家予防接種スケジュールを通じて主要血清型に対する予防接種プログラムを推進する政府や保健機関のイニシアティブの高まりが、髄膜炎菌ワクチンの摂取を後押ししています。新たな血清群に対する防御を提供する新世代の多価髄膜炎菌ワクチンの採用は、市場参入者に機会を記載しています。しかし、新たな髄膜炎菌ワクチンの開発に関連する高い研究開発費は、代替治療オプションの利用可能性とともに、市場成長の妨げとなる可能性があります。

本調査の主要特徴

• 本レポートでは、世界の髄膜炎菌ワクチン市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
• 本レポートでは、髄膜炎菌ワクチンの世界市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
• 本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 髄膜炎菌ワクチンの世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者を対象としています。
• 利害関係者は、世界の髄膜炎菌ワクチン市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の髄膜炎菌ワクチン市場-コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の髄膜炎菌ワクチン市場、タイプ別、2020～2032年（10億米ドル）

• イントロダクション
• 多糖類ワクチン
• 結合ワクチン
• 混合ワクチン
• その他

第6章 世界の髄膜炎菌ワクチン市場、販売チャネル別、2020～2032年（10億米ドル）

• イントロダクション
• 公共
• 民間

第7章 世界の髄膜炎菌ワクチン市場、年齢層別、2020～2032年（10億米ドル）

• イントロダクション
• 乳児（0～2歳）
• 幼児と成人（2歳以上）

第8章 世界の髄膜炎菌ワクチン市場、地域別、2020～2032年（10億米ドル）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.
  • Walvax BIoTechnology Co., Ltd.
  • Hualan Biological Engineering Inc.
  • JN-International Medical Corporation
  • Beijing Minhai BIoTechnology Co., Ltd
  • Bio-Manguinhos/Fiocruz
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Baxter International
  • CSL Limited
  • Bavarian Nordic
  • Incepta Vaccine Ltd.
  • Sinovac BIoTech Ltd.
  • Novartis
  • Panacea BIoTec Ltd

第10章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Meningococcal Vaccines Market is estimated to be valued at USD 4.53 Bn in 2025 and is expected to reach USD 9.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Figure. Meningococcal Vaccines Market Share (%), By Region 2025

Meningococcal disease refers to the bacterial infections causing meningitis and sepsis that can lead to serious illness or even death, if not promptly treated. Rising prevalence of these invasive meningococcal diseases along with growing awareness about the availability of effective vaccines against such infections can boost demand for meningococcal vaccines globally. Furthermore, ongoing research & development activities for new conjugate vaccines against additional serotypes and expanding vaccination programs worldwide can offer numerous opportunities for market players in the near future. However, factors such as high costs associated with vaccine development and threats of substitutes can hamper the market growth.

Market Dynamics:

Global meningococcal vaccines market growth is driven by rising prevalence of invasive meningococcal diseases worldwide due to changing demographics and lifestyle patterns. According to the World Health Organization (WHO), approximately 1.2 million cases of meningococcal meningitis occur every year across the globe, leading to around 135,000 deaths. Growing initiatives by governments and health agencies to promote immunization programs against major serotypes through national vaccination schedules boosts uptake of meningococcal vaccines. Introduction of newer generation multivalent meningococcal vaccines providing protection against additional serogroups can offer opportunities for market players. However, high research and development costs associated with development of novel meningococcal vaccines along with availability of alternative treatment options can hamper the market growth.

Key Features of the Study:

• This report provides in-depth analysis of the global meningococcal vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global meningococcal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi SA, Pfizer Inc., Merck & Co., Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global meningococcal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningococcal vaccines market

Detailed Segmentation-

• By Type
  • Polysaccharide Vaccines
  • Conjugate Vaccines
  • Combination Vaccines
  • Other
• By Sales Channel
  • Public
  • Private
• By Age Group
  • Infants (0 to 2 years)
  • Children and Adults (2 years & above)
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.
  • Walvax Biotechnology Co., Ltd.
  • Hualan Biological Engineering Inc.
  • JN-International Medical Corporation
  • Beijing Minhai Biotechnology Co., Ltd
  • Bio-Manguinhos/Fiocruz
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Baxter International
  • CSL Limited
  • Bavarian Nordic
  • Incepta Vaccine Ltd.
  • Sinovac Biotech Ltd.
  • Novartis
  • Panacea Biotec Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Sales Channel
  • Market Snapshot, By Age Group
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Meningococcal Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Meningococcal Vaccines Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Polysaccharide Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Conjugate Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Combination Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Meningococcal Vaccines Market, By Sales Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Public
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Private
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Meningococcal Vaccines Market, By Age Group, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Infants (0 to 2 years)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Children and Adults (2 years & above)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Meningococcal Vaccines Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • GlaxoSmithKline plc
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi Pasteur
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Walvax Biotechnology Co., Ltd.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hualan Biological Engineering Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • JN-International Medical Corporation
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Beijing Minhai Biotechnology Co., Ltd
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Manguinhos/Fiocruz
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Baxter International
  • CSL Limited
  • Bavarian Nordic
  • Incepta Vaccine Ltd.
  • Sinovac Biotech Ltd.
  • Novartis
  • Panacea Biotec Ltd

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact